If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMADE.L Regulatory News (MADE)

  • There is currently no data for MADE

Response to press speculation

18 Aug 2022 07:00

RNS Number : 3973W
Made.com Group Plc
18 August 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

THIS STATEMENT CONTAINS INSIDE INFORMATION

 

17 August 2022

 

Made.com Group Plc

("MADE" or "the Group")

 

RESPONSE TO PRESS SPECULATION

 

Further to the Q2 trading update published on 19 July 2022, MADE notes the recent press speculation regarding the possibility of the Group undertaking a capital raise.

 

As indicated in the Q2 trading update, MADE is considering all options to allow it to strengthen its balance sheet. MADE confirms that these options include a potential equity capital raise. MADE continues to consider its options and a further announcement will be made if and when appropriate.

 

 

ENDS

 

 

Enquiries:

 

MADE

Nicola Thompson, Chief Executive Officer

Patrick Lewis, Chief Financial Officer

Phil Clark, Investor Relations

investor.relations@made.com

 

Brunswick Group

Sarah West, James Baker, Craig Breheny

made@brunswickgroup.com

+44 207 404 5959

 

The person responsible for making this announcement on behalf of Made.com Group Plc is Laura Tyler, General Counsel and Company Secretary (Interim).

 

About MADE

MADE is the leading digitally native lifestyle brand in home, disrupting the industry with high-quality, exclusive designs underpinned by a responsible, small-batch production model, enabling customers to realise the vision of their homes.

 

In addition to its in-house design team and collaborations with leading designers, MADE champions independent talent, offering them a platform and access to a scalable supply chain that makes their ideas reality. These partners bring their unique perspective in the creation of bold statement collections and work with MADE to produce iconic designs.

 

Operating at the intersection of design and technology, proprietary algorithms take consumers on a journey: from outreach that makes designs discoverable to a frictionless digital shopping experience. Combined with an innovative 'just-in-time' order model, MADE provides a fresh and ever-changing range, with nine new collections launched every week and more than 8,000 active SKUs in the catalogue as at 30 June 2022.

 

Founded in 2010, MADE sells its products across the United Kingdom, Germany, Switzerland, Austria, France, Belgium, Spain, Ireland and the Netherlands via its e-commerce platform. The brand also has seven showrooms across Europe, with flagship brand experiences in London and Paris.

 

LEI: 213800HTMSVKO71K6O71

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCGPUQWRUPPPGM
Date   Source Headline
21st Jun 202212:41 pmRNSBlock Listing Application
16th May 20227:01 amRNSDirectorate Change
16th May 20227:00 amRNSTrading Update
9th May 20227:00 amRNSAcquisition
5th May 20224:23 pmRNSResult of AGM
5th May 20228:30 amRNSDirectorate Change
11th Apr 202211:59 amRNSHolding(s) in Company
6th Apr 202212:43 pmRNSDirector/PDMR Shareholding
1st Apr 202212:25 pmRNSNotice of AGM
25th Mar 20227:00 amRNSDirectorate Change
17th Mar 202211:26 amRNSAnnual Financial Report
8th Mar 20227:00 amRNSPreliminary Results
28th Feb 202211:26 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change
31st Jan 202210:17 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSTrading Statement
31st Dec 20219:38 amRNSTotal Voting Rights
21st Dec 202110:31 amRNSBlock listing Interim Review
15th Dec 20213:31 pmRNSCompletion of Capital Reduction
9th Dec 20217:00 amRNSTrading Update
30th Nov 202111:01 amRNSTotal Voting Rights
29th Oct 202110:08 amRNSTotal Voting Rights
30th Sep 202110:07 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
31st Aug 202110:42 amRNSTotal Voting Rights
3rd Aug 20215:01 pmRNSHolding(s) in Company
30th Jul 202111:21 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSNotice of Half Year Results
30th Jul 20217:00 amRNSAppointment of Joint Corporate Brokers
23rd Jul 20212:46 pmRNSHolding(s) in Company
23rd Jul 20211:47 pmRNSHolding(s) in Company
16th Jul 20217:00 amRNSStabilisation Notice
16th Jul 20217:00 amRNSExercise of Over-allotment Option
14th Jul 20217:00 amRNSStabilisation Notice
13th Jul 20214:17 pmRNSDirector/PDMR Shareholding
7th Jul 20217:00 amRNSStabilisation Notice
1st Jul 202112:10 pmRNSHolding(s) in Company
1st Jul 202112:08 pmRNSHolding(s) in Company
30th Jun 202112:10 pmRNSTotal Voting Rights
30th Jun 20217:00 amRNSStabilisation Notice
24th Jun 202110:58 amRNSHolding(s) in Company
24th Jun 202110:47 amRNSDirector/PDMR Shareholding - Correction
23rd Jun 20212:35 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSStabilisation Notice
21st Jun 202110:21 amRNSDirector/PDMR Shareholding
21st Jun 202110:15 amRNSHolding(s) in Company
21st Jun 20218:00 amRNSAdmission to Trading
17th Jun 202111:03 amRNSBlock Listing Application
16th Jun 20211:26 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.